---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-23-000063"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2023-08-09T23:59:59+00:00"
generated_at: "2026-06-11T22:20:12.383407+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Avanos Q2 sales $169.4M, adjusted EPS $0.24; FY2023 adjusted EPS guidance $1.05-$1.15

## Summary
- Q2 net sales $169.4M (-0.9% YoY); net loss $4.3M vs net income $4.8M a year ago.
- Adjusted diluted EPS $0.24 vs $0.26; adjusted EBITDA flat at $22.9M.
- Closed Diros Technologies acquisition (RFA) in July; recorded $72.3M impairment on Respiratory Health divestiture.
- UK NICE recommends RFA for osteoarthritic knee pain, potentially improving Pain Management reimbursement.
- FY2023 outlook: adjusted EPS $1.05-$1.15, adjusted gross margin >59%, H2 organic growth low single-digit.

## SEC filing metadata
- accession: 0001606498-23-000063
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2023-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000063/0001606498-23-000063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000063/avns-20230809.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-23-000063
- JSON: https://secwatch.observer/filing/0001606498-23-000063.json
- Plain text: https://secwatch.observer/filing/0001606498-23-000063.txt

## Key facts
- Earnings Releases
  AVANOS MEDICAL, INC. reported financial results for the three and six months ended June 30, 2023.
  - Period: the three and six months ended June 30, 2023
  - Result: reported results
  source text: Avanos Medical, Inc. (the “Company”) announced its results of operations for the three and six months ended June 30, 2023 in a press release dated August 9, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000063/0001606498-23-000063-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.